Hepamerz%25252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252520%25252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252528l-Ornithine%25252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252520l-Aspartate%25252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252520-%25252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252520lola%25252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252529

## Hepamerz (l-ornithine l-aspartate) ### Overview Hepamerz is a combination of two amino acids, l-ornithine and l-aspartate. It is primarily used in the management of hyperammonemia associated with liver conditions. The mechanism involves promoting the detoxification of ammonia in the liver by enhancing its conversion to urea (urea cycle) and glutamine. ### Primary Indications * Management of hyperammonemia in patients with liver cirrhosis. * Treatment of hepatic encephalopathy. ### Adult Dosing * **Intravenous:** Typically administered as an infusion. Common doses range from 10 to 30 grams per day, often divided into 2-3 infusions. A standard regimen can be 5 grams (equivalent to one 10mL ampoule containing 5g/10mL) twice daily, or up to 10 grams (equivalent to two 10mL ampoules) three times daily. The maximum daily dose is generally 30 grams. Infusion rate should not exceed 5 grams per hour. * **Oral:** Doses typically range from 3 grams to 6 grams three times daily. Dosing frequency and duration should be guided by the patient's clinical response and ammonia levels. Specific protocols may vary. ### Pediatric Dosing * Pediatric dosing is not well-established and should be determined by a specialist. Use with caution and under close medical supervision. ### Dose Adjustments * No specific dose adjustments are typically required for renal or hepatic impairment, as the drug's action is primarily within the liver. However, close monitoring of ammonia levels is crucial in patients with severe liver disease. ### Contraindications * Severe renal insufficiency (creatinine clearance < 25 mL/min). * Known hypersensitivity to l-ornithine or l-aspartate. * Hyperornithinemia-hyperammonemia-encephalopathy (HHH) syndrome. ### Adverse Effects * **Common:** Nausea, vomiting, abdominal discomfort, diarrhea. * **Less Common:** Dizziness, headache, fatigue, skin rash. * **Rare:** Allergic reactions. ### Key Drug Interactions * No significant drug interactions are well-documented. However, caution should be exercised if co-administering with other medications affecting ammonia metabolism or renal function. ### Monitoring * Serum ammonia levels. * Renal function (serum creatinine, BUN). * Electrolytes. * Clinical signs and symptoms of hepatic encephalopathy. ### Clinical Pearls * L-ornithine l-aspartate can be administered concurrently with other treatments for liver disease. * Ensure adequate hydration when administering intravenously. * The oral formulation can be mixed with fluids or other beverages. *** **Disclaimer:** This information is intended for healthcare professionals and is not a substitute for professional medical advice. Always consult the most current prescribing information and guidelines, or a qualified healthcare provider, to ensure patient safety and appropriate treatment.